Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup

por Alles, M. Chehani, Gardiner-Garden, Margaret, Nott, David J., Wang, Yixin, Foekens, John A., Sutherland, Robert L., Musgrove, Elizabeth A., Ormandy, Christopher J.
Publicado 2009

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study

por Sieuwerts, Anieta M, Ansems, Marleen, Look, Maxime P, Span, Paul N, de Weerd, Vanja, van Galen, Anne, Foekens, John A, Adema, Gosse J, Martens, John WM
Publicado 2010

Genome-wide DNA methylation profiling of non-small cell lung carcinomas

por Carvalho, Rejane Hughes, Haberle, Vanja, Hou, Jun, van Gent, Teus, Thongjuea, Supat, van IJcken, Wilfred, Kockx, Christel, Brouwer, Rutger, Rijkers, Erikjan, Sieuwerts, Anieta, Foekens, John, van Vroonhoven, Mirjam, Aerts, Joachim, Grosveld, Frank, Lenhard, Boris, Philipsen, Sjaak
Publicado 2012

Structural and Functional Analysis of the Pore-Forming Toxin NetB from Clostridium perfringens

por Yan, Xu-Xia, Porter, Corrine J., Hardy, Simon P., Steer, David, Smith, A. Ian, Quinsey, Noelene S., Hughes, Victoria, Cheung, Jackie K., Keyburn, Anthony L., Kaldhusdal, Magne, Moore, Robert J., Bannam, Trudi L., Whisstock, James C., Rood, Julian I.
Publicado 2013

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis

por Weerts, Marjolein J.A., Sieuwerts, Anieta M., Smid, Marcel, Look, Maxime P., Foekens, John A., Sleijfer, Stefan, Martens, John W.M.
Publicado 2016

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor()

por Beije, Nick, Onstenk, Wendy, Kraan, Jaco, Sieuwerts, Anieta M., Hamberg, Paul, Dirix, Luc Y., Brouwer, Anja, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Van, Ngoc M., Foekens, John A., Martens, John W.M., Sleijfer, Stefan
Publicado 2016

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer

por Onstenk, Wendy, Sieuwerts, Anieta M., Mostert, Bianca, Lalmahomed, Zarina, Bolt-de Vries, Joan B., van Galen, Anne, Smid, Marcel, Kraan, Jaco, Van, Mai, de Weerd, Vanja, Ramírez-Moreno, Raquel, Biermann, Katharina, Verhoef, Cornelis, Grünhagen, Dirk J., IJzermans, Jan N.M., Gratama, Jan W., Martens, John W.M., Foekens, John A., Sleijfer, Stefan
Publicado 2016

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA()()

por Weerts, M.J.A., Timmermans, E.C., van de Stolpe, A., Vossen, R.H.A.M., Anvar, S.Y., Foekens, J.A., Sleijfer, S., Martens, J.W.M.
Publicado 2018

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

por Brinkman, Arie B., Nik-Zainal, Serena, Simmer, Femke, Rodríguez-González, F. Germán, Smid, Marcel, Alexandrov, Ludmil B., Butler, Adam, Martin, Sancha, Davies, Helen, Glodzik, Dominik, Zou, Xueqing, Ramakrishna, Manasa, Staaf, Johan, Ringnér, Markus, Sieuwerts, Anieta, Ferrari, Anthony, Morganella, Sandro, Fleischer, Thomas, Kristensen, Vessela, Gut, Marta, van de Vijver, Marc J., Børresen-Dale, Anne-Lise, Richardson, Andrea L., Thomas, Gilles, Gut, Ivo G., Martens, John W. M., Foekens, John A., Stratton, Michael R., Stunnenberg, Hendrik G.
Publicado 2019

Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes

por Koedoot, Esmee, Fokkelman, Michiel, Rogkoti, Vasiliki-Maria, Smid, Marcel, van de Sandt, Iris, de Bont, Hans, Pont, Chantal, Klip, Janna E., Wink, Steven, Timmermans, Mieke A., Wiemer, Erik A. C., Stoilov, Peter, Foekens, John A., Le Dévédec, Sylvia E., Martens, John W. M., van de Water, Bob
Publicado 2019

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer

por van der Noord, Vera E., McLaughlin, Ronan P., Smid, Marcel, Foekens, John A., Martens, John W. M., Zhang, Yinghui, van de Water, Bob
Publicado 2019

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

por Hammerl, Dora, Martens, John W. M., Timmermans, Mieke, Smid, Marcel, Trapman-Jansen, Anita M., Foekens, Renée, Isaeva, Olga I., Voorwerk, Leonie, Balcioglu, Hayri E., Wijers, Rebecca, Nederlof, Iris, Salgado, Roberto, Horlings, Hugo, Kok, Marleen, Debets, Reno
Publicado 2021

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

por Klijn, J. G., Hoff, A. M., Planting, A. S., Verweij, J., Kok, T., Lamberts, S. W., Portengen, H., Foekens, J. A.
Publicado 1990

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.

por Foekens, J. A., Portengen, H., Look, M. P., van Putten, W. L., Thirion, B., Bontenbal, M., Klijn, J. G.
Publicado 1994

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.

por Schuyer, M., van Staveren, I. L., Klijn, J. G., vd Burg, M. E., Stoter, G., Henzen-Logmans, S. C., Foekens, J. A., Berns, E. M.
Publicado 1996

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

por Foekens, J A, Look, M P, Vries, J Bolt-de, Gelder, M E Meijer-van, Putten, W L J van, Klijn, J G M
Publicado 1999

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

por Foekens, J A, Diamandis, E P, Yu, H, Look, M P, Gelder, M E Meijer-van, Klijn, J G M
Publicado 1999

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

por Toussaint, Jérôme, Sieuwerts, Anieta M, Haibe-Kains, Benjamin, Desmedt, Christine, Rouas, Ghizlane, Harris, Adrian L, Larsimont, Denis, Piccart, Martine, Foekens, John A, Durbecq, Virginie, Sotiriou, Christos
Publicado 2009

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

por Jansen, M. P. H. M., Reijm, E. A., Sieuwerts, A. M., Ruigrok-Ritstier, K., Look, M. P., Rodríguez-González, F. G., Heine, A. A. J., Martens, J. W., Sleijfer, S., Foekens, J. A., Berns, E. M. J. J.
Publicado 2011

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib

por Godinho, M F E, Wulfkuhle, J D, Look, M P, Sieuwerts, A M, Sleijfer, S, Foekens, J A, Petricoin, E F, Dorssers, L C J, van Agthoven, T
Publicado 2012